MacroGenics (MGNX) Q3 2024 Earnings Call Transcript

By Yahoo! Finance | Nov 5, 2024 at 10:23 PM EST

MacroGenics recently reported strong financial results for the quarter, including a revenue increase and net income boost. The company's focus on B7-H3 assets like vobra duo and MGC026 shows promise for the future. CEO Dr. Scott Koenig highlighted ongoing clinical programs and future prospects.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.